Clinical Trial Update: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of sorafenib with cisplatin and 5-fluorouracil as first-line therapy for patients with recurrent or metastatic nasopharyn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED